Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.

Blauvelt A, Guttman-Yassky E, Lynde C, Khattri S, Schlessinger J, Imafuku S, Tada Y, Morita A, Wiseman M, Kwiek B, Machkova M, Zhang P, Linaberry M, Li J, Zhang S, Franchin G, Charles ED, De Oliveira CHMC, Silverberg JI

Open source

DOI: 10.1001/jamadermatol.2024.2131
Published: 2024 Aug 1
Container: JAMA dermatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2024.2131,
  title = {Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.},
  author = {Blauvelt A and Guttman-Yassky E and Lynde C and Khattri S and Schlessinger J and Imafuku S and Tada Y and Morita A and Wiseman M and Kwiek B and Machkova M and Zhang P and Linaberry M and Li J and Zhang S and Franchin G and Charles ED and De Oliveira CHMC and Silverberg JI},
  year = {2024},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2024.2131},
  url = {https://doi.org/10.1001/jamadermatol.2024.2131}
}

RIS

TY  - JOUR
TI  - Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
AU  - Blauvelt A
AU  - Guttman-Yassky E
AU  - Lynde C
AU  - Khattri S
AU  - Schlessinger J
AU  - Imafuku S
AU  - Tada Y
AU  - Morita A
AU  - Wiseman M
AU  - Kwiek B
AU  - Machkova M
AU  - Zhang P
AU  - Linaberry M
AU  - Li J
AU  - Zhang S
AU  - Franchin G
AU  - Charles ED
AU  - De Oliveira CHMC
AU  - Silverberg JI
PY  - 2024
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2024.2131
UR  - https://doi.org/10.1001/jamadermatol.2024.2131
ER  -

APA

A, B., E, G., C, L., S, K., J, S., S, I., Y, T., A, M., M, W., B, K., M, M., P, Z., M, L., J, L., S, Z., G, F., ED, C., CHMC, D. O., & JI, S. (2024). Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2024.2131

Source records

pubmed · retrieved 2026-09-26T11:20:05.294Z
europe-pmc · retrieved 2026-09-26T11:20:05.311Z